Top 3D Printing companies in Australia by Current Liabilities
Australia
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 421.06 M
|
June 30, 2024 | USD 196.75 | 0.54% |
|
Australia |
|
| 2 |
USD 107.20 M
|
Dec. 31, 2023 | USD 18.31 | -0.05% |
|
Australia |
|
| 3 |
USD 103.62 M
|
June 30, 2024 | USD 10.60 | 2.82% |
|
Australia |
|
| 4 |
USD 79.23 M
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
| 5 |
USD 73.24 M
|
June 30, 2024 | USD 1.84 | -3.30% |
|
Australia |
|
| 6 |
USD 58.11 M
|
June 30, 2024 | USD 1.89 | -0.64% |
|
Australia |
|
| 7 |
USD 23.04 M
|
June 30, 2024 | USD 181.01 | -0.30% |
|
Australia |
|
| 8 |
USD 15.50 M
|
June 30, 2024 | USD 1.23 | 0.02% |
|
Australia |
|
| 9 |
USD 15.09 M
|
June 30, 2024 | USD 5.22 | 1.36% |
|
Australia |
|
| 10 |
USD 9.42 M
|
Dec. 31, 2023 | USD 6.22 | 1.04% |
|
Australia |
|
| 11 |
USD 5.90 M
|
Dec. 31, 2023 | USD 1.45 | -0.42% |
|
Australia |
|
| 12 |
USD 5.75 M
|
June 30, 2024 | USD 3.87 | 2.52% |
|
Australia |
Frequently Asked Questions
-
Which 3D Printing company in Australia has the highest Current Liabilities ?
The 3D Printing company in Australia with the highest Current Liabilities is Cochlear Limited (ASX: COH.AX) at USD 421.06 M.
-
Which 3D Printing company in Australia has the lowest Current Liabilities ?
The 3D Printing company in Australia with the lowest Current Liabilities is Silex Systems Limited (ASX: SLX.AX) at USD 5.75 M.
-
What are the top 10 3D Printing companies in Australia by Current Liabilities ?
The top 10 3D Printing companies in Australia by Current Liabilities are Cochlear Limited, Telix Pharmaceuticals Limited, Codan Limited, Monash IVF Group Limited, Mesoblast Limited, Integral Diagnostics Limited, Pro Medicus Limited, PolyNovo Limited, PWR Holdings Limited and Anteris Technologies Ltd.
-
What are the bottom 10 3D Printing companies in Australia by Current Liabilities ?
The bottom 10 3D Printing companies in Australia by Current Liabilities are Silex Systems Limited, Cyclopharm Limited, Anteris Technologies Ltd, PWR Holdings Limited, PolyNovo Limited, Pro Medicus Limited, Integral Diagnostics Limited, Mesoblast Limited, Monash IVF Group Limited and Codan Limited.
